Skip to content

clinical trial to ensure the safety and efficacy of Phakic intraocular lenses in high myopic patients

To assess the safety and efficacy of posterior chamber phakic intraocular lens (PCPIOL) in patients with high myopia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/04/051897
Enrollment
9
Registered
2023-04-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H55-H57- Other disorders of eye and adnexa

Interventions

Intervention1: Phakic intraocular lens: Phakic intraocular lens is an innovative emerging technology with an optical design intended to correct widest range of myopia (nearsightedness) hyperopia (fars

Sponsors

Aurolab
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a) Adults of > 21 years b) Stable refraction atleast for 1 year c) Myopia and Myopic astigmatism less than 1 D of corneal astigmatism d) Clear intraocular media e) Intraocular pressure of f) Anterior chamber depth of atleast 2.8 mm and angle g) Endothelial cell count >2500 cells/mm2 h) Normal posterior segment i) AS OCT (Open angles) j) Abnormal elevation and curvature maps not fit for corneal refractive surgery. k) understand and willing to participate in the study for 2 years of follow up period l) No systemic illness

Exclusion criteria

Exclusion criteria: a) Participation in any other drug or device clinical trial within 90 days prior to enrolling in this study and/or during study participation b) corneal pathologic conditions like degenerations and dystrophies and keratoconus c) Evidence of any lens opacity or developing cataract, pseudoexfoliation or pigmentory dispersion d) History of glaucoma and uveitis e) Previous history of ocular diseases f) History of any intraocular or corneal surgery in either eye (including LASIK PRK LRI etc) g) Anterior chamber depth h) Pregnancy and lactation

Design outcomes

Secondary

MeasureTime frame
visual acuity Post operative complications Contrast sensitivityTimepoint: 24 months

Primary

MeasureTime frame
a) Uncorrected visual acuity b) Best corrected visual acuity c) Intraocular Pressure d) Endothelial cell count e) Post operative inflammationTimepoint: day 1 one month three months six months 12 months 18 months 24 months

Countries

India

Contacts

Public ContactDr Meenakshi Ravindran

Aravind Eye Hospital

drmeenakshi@aravind.org04624356100

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026